Phthalocyanines can be administered through various routes such as intravenous injection or topical application, depending on the type and location of the tumor. Once administered, the compound accumulates preferentially in cancer cells. The treatment area is then exposed to a specific wavelength of light, typically in the red or near-infrared spectrum, to activate the phthalocyanine.
